Home › Companies › Mesa Laboratories, Inc. › 2024-2025

Mesa Laboratories, Inc. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and Mesa Laboratories, Inc.’s Form 8-K, filed 2024-08-30 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 231Asset managers
  • 2,062Fund votes
  • 2024-08-30Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Mesa Laboratories, Inc. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by Mesa Laboratories, Inc.

These tallies are Mesa Laboratories, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-08-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Mesa Laboratories, Inc. — official shareholder meeting results, meeting held 2024-08-30
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: John J. Sullivan, Ph.D. 4,759,234---- 81,652255,479 Majority: yes
Elect Director: Gary M. Owens 4,732,565---- 108,321255,479 Majority: yes
Elect Director: Shannon M. Hall 4,727,530---- 113,356255,479 Majority: yes
Elect Director: Jennifer S. Alltoft 4,667,909---- 172,977255,479 Majority: yes
Elect Director: Shiraz S. Ladiwala 4,818,063---- 22,823255,479 Majority: yes
Elect Director: R. Tony Tripeny 4,812,667---- 28,219255,479 Majority: yes
Elect Director: Mark Capone 4,832,466---- 8,420255,479 Majority: yes
Proposal 2: Ratification of the selection by our Audit Committee of RSM US LLP to serve as the Company ' s independent registered public accounting firm for the fiscal year ending March 31, 2025 The appointment of RSM US LLP as the Company's independent regist 4,992,593103,362410 ---- Majority: yes
Proposal 3: Approval on a non-binding basis of the compensation of Mesa ' s named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a non-binding advisory basis. 4,581,083226,77333,030 --255,479 Majority: yes

Source: Mesa Laboratories, Inc., Form 8-K, filed with the SEC on 2024-08-30 — read the filing on EDGAR.

How asset managers voted at the Mesa Laboratories, Inc. 2024-2025 meeting

Each item below shows how the 231 asset managers that disclosed a Mesa Laboratories, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Mesa Laboratories, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on an advisory basis, the Company's named executive officer compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 4,581,083AGAINST: 226,773

Mesa Laboratories, Inc.’s own tally for this item (“Proposal 3: Approval on a non-binding basis of the compensation of Mesa ' s named executive officers The compensation of the Company's named executive officers, as disclosed in the proxy statement, was approved on a non-”): 4,581,083 for, 226,773 against, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 225 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%
FOR: 96.8%AGAINST: 3.2%
Largest asset managers voting on “To approve, on an advisory basis, the Company's named executive officer compensation.” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock676,7552,314 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard368,7190 00For
State Street250,27072 00For
Ranger Investment Management, L.P.214,6480 00For
Conestoga Capital Advisors, LLC166,0960 00For
GENEVA CAPITAL MANAGEMENT LLC161,4360 00For
ATLANTA CAPITAL MANAGEMENT CO L L C155,2080 00For
EAGLE ASSET MANAGEMENT INC154,3570 00For
JANUS INVESTMENT FUND121,0070 00For
GEODE CAPITAL MANAGEMENT, LLC116,4610 00For
Fidelity113,014209 00For
Bridge Builder Trust108,4210 00For
Russell Investments93,8520 00For
Charles Schwab87,2320 00For
GLENMEDE FUND INC86,8860 00For
Northern Trust85,7980 00For
Dimensional83,6930 00For
RAYMOND JAMES & ASSOCIATES80,5540 00For
KENNEDY CAPITAL MANAGEMENT LLC64,4630 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM033,240 00Against
RBC Capital Markets, LLC32,4390 00For

Showing the 25 largest of 225 asset managers. See all 225 in the interactive database.

2. To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,992,593AGAINST: 103,362

Mesa Laboratories, Inc.’s own tally for this item (“Proposal 2: Ratification of the selection by our Audit Committee of RSM US LLP to serve as the Company ' s independent registered public accounting firm for the fiscal year ending March 31, 2025 The appointment of RSM US”): 4,992,593 for, 103,362 against, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 92% for, 2% against (94% of the company cast a for/against vote).

The 71 asset managers below cast 100% of the shares they voted on this item FOR (2,720,423 for, 0 against).

FOR 100%
FOR: 2,720,423 (100.0%)
Largest asset managers voting on “To ratify the appointment of RSM US LLP as the Company's independent registered public accounting firm for the” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5740 00For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

3. Election of directors: G. Owens

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,732,565WITHHELD: 108,321

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Gary M. Owens”): 4,732,565 for, 108,321 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 87% for, 2% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,712,791 for, 0 against).

FOR 99.9%
FOR: 2,712,791 (100.0%)ABSTAIN: 13 (0.0%)
Largest asset managers voting on “Election of directors: G. Owens” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5610 130For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

4. Election of directors: J. Alltoft

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 4,667,909WITHHELD: 172,977

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Jennifer S. Alltoft”): 4,667,909 for, 172,977 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 86% for, 3% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,670,703 for, 0 against).

FOR 98%
FOR: 2,670,703 (98.4%)ABSTAIN: 42,101 (1.6%)
Largest asset managers voting on “Election of directors: J. Alltoft” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust102,6570 5,7640For
State Street90,5470 270For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS00 13,9160Abstain
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

5. Election of directors: J. Sullivan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,759,234WITHHELD: 81,652

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: John J. Sullivan, Ph.D.”): 4,759,234 for, 81,652 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 88% for, 2% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,684,869 for, 0 against).

FOR 99%
FOR: 2,684,869 (99.0%)ABSTAIN: 27,935 (1.0%)
Largest asset managers voting on “Election of directors: J. Sullivan” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5590 150For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.00 21,3090Abstain
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

6. Election of directors: M. Capone

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 4,832,466WITHHELD: 8,420

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Mark Capone”): 4,832,466 for, 8,420 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 89% for, 0.2% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,712,804 for, 0 against).

FOR 100%
FOR: 2,712,804 (100.0%)
Largest asset managers voting on “Election of directors: M. Capone” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5740 00For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

7. Election of directors: T. Tripeny

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 4,812,667WITHHELD: 28,219

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: R. Tony Tripeny”): 4,812,667 for, 28,219 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 89% for, 0.6% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,707,601 for, 0 against).

FOR 99.8%
FOR: 2,707,601 (99.8%)ABSTAIN: 5,203 (0.2%)
Largest asset managers voting on “Election of directors: T. Tripeny” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5610 130For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable8,5720 5,1900For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

8. Election of directors: S. Hall

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 4,727,530WITHHELD: 113,356

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shannon M. Hall”): 4,727,530 for, 113,356 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 87% for, 2% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,679,477 for, 0 against).

FOR 99%
FOR: 2,679,477 (98.8%)ABSTAIN: 33,327 (1.2%)
Largest asset managers voting on “Election of directors: S. Hall” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust102,6570 5,7640For
State Street90,5470 270For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS00 13,9160Abstain
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

9. Election of directors: S. Ladiwala

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 4,818,063WITHHELD: 22,823

Mesa Laboratories, Inc.’s own tally for this item (“Elect Director: Shiraz S. Ladiwala”): 4,818,063 for, 22,823 withheld, per its Form 8-K filed 2024-08-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 5,409,155 outstanding shares: 89% for, 0.5% withheld (89% of the company cast a for/withheld vote).

The 68 asset managers below cast 100% of the shares they voted on this item FOR (2,712,791 for, 0 against).

FOR 99.9%
FOR: 2,712,791 (100.0%)ABSTAIN: 13 (0.0%)
Largest asset managers voting on “Election of directors: S. Ladiwala” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
BlackRock557,8180 00For
CONESTOGA FUNDS405,4810 00For
Royce394,5010 00For
Vanguard355,7030 00For
JANUS INVESTMENT FUND121,0070 00For
Fidelity113,0140 00For
Bridge Builder Trust108,4210 00For
State Street90,5610 130For
GLENMEDE FUND INC86,8860 00For
Dimensional65,8500 00For
Columbia Threadneedle52,1930 00For
Nationwide49,0270 00For
Charles Schwab42,1060 00For
Russell Investments39,0570 00For
Keeley Funds, Inc.21,3090 00For
Transamerica17,3990 00For
WisdomTree13,9900 00For
ALGER FUNDS13,9160 00For
Equitable13,7620 00For
TIAA12,9860 00For
Jackson National12,2080 00For
Victory Capital12,1360 00For
QUANTITATIVE MASTER SERIES LLC10,2750 00For
BNY Mellon8,6520 00For
SPEND LIFE WISELY FUNDS INVESTMENT TRUST6,9000 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

10. DIRECTOR

DIRECTOR ELECTIONS

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (7,619 for, 0 against).

FOR: 7,619 (100.0%)
Largest asset managers voting on “DIRECTOR” at Mesa Laboratories, Inc., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Zacks Trust4,2500 00For
TETON WESTWOOD FUNDS3,0000 00For
Vantage Consulting Group Inc3690 00For

Largest Mesa Laboratories, Inc. shareholders voting in 2024-2025

Ranked by the number of Mesa Laboratories, Inc. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 5,409,155 shares outstanding at the time of that meeting.

Top Mesa Laboratories, Inc. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1BlackRock 12.55%
2CONESTOGA FUNDS 7.50%
3Royce 7.29%
4Vanguard 6.82%
5State Street 4.63%
6Ranger Investment Management, L.P. 3.97%
7Conestoga Capital Advisors, LLC 3.07%
8GENEVA CAPITAL MANAGEMENT LLC 2.98%
9ATLANTA CAPITAL MANAGEMENT CO L L C 2.87%
10EAGLE ASSET MANAGEMENT INC 2.85%

Reported Mesa Laboratories, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Mesa Laboratories, Inc. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
BlackRock 15.30% 13F
Conestoga Capital Advisors 11.43% 13G
Vanguard Group 7.11% 13F
ROYCE & ASSOCIATES LP 5.01% 13G
State Street 4.06% 13F
Morgan Stanley 4.00% 13F
Gary Owens 2.36% DEF14A
Dimensional Fund Advisors 2.06% 13F
Northern Trust 1.52% 13F
John Sullivan Ph.D. 1.31% DEF14A

Percentages above are of 5,409,155 shares outstanding, as reported by Mesa Laboratories, Inc. on its Form 10-Q dated 2024-06-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Mesa Laboratories, Inc.’s 10-Q dated 2024-06-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Mesa Laboratories, Inc.'s shareholder meeting held 2024-08-30, in the 2024-2025 proxy season, 231 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,062 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the Company's named executive officer compensation. — FOR was 95% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Mesa Laboratories, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-08-30.

Mesa Laboratories, Inc. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.